Macquarie upgrades Sandfire Resources earnings forecasts and price target

Published 25-JAN-2017 15:56 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

After reviewing Sandfire Resources’ results for the three months to December 31, 2017 analysts at Macquarie have increased their earnings estimates for fiscal years 2017 and 2018 by 11% and 4% respectively.

Sandfire still has scope to expand production at its DeGrussa copper gold project located in Western Australia. The company is also looking to develop the nearby Monty project, one of the highest grade VMS (Volcanogenic Massive Sulphide) deposits discovered anywhere in the world in the past three decades.

With regard to today’s upgrades, the broker also took into account lower cash costs and quotational pricing which will potentially drive higher cash generation and enable the early payment of its $50 million debt facility.

Macquarie sees the Monty feasibility study which should be released in the second quarter of calendar year 2017 as a potential share price catalyst. It has factored in production in the order of 20,000 tonnes from Monty in fiscal 2019.

With improved operational performances and other potential positive catalysts on the horizon the broker upgraded its target price from $7.00 to $7.50.

40% increase in profit forecast in fiscal 2018

While Sandfire is forecast to generate substantial profit growth in fiscal 2017, it is really a 2018 story with the company generating stronger revenues off a similar cost base, resulting in net profit increasing from $85 million to $118 million based on Macquarie’s forecasts.

This represents earnings per share of 74.6 cents, indicating that Macquarie’s price target implies a PE multiple of approximately 10.

The broker is also expecting Sandfire to pay a dividend of 22 cents in fiscal 2018, implying a yield of more than 3% based on the company’s current trading range, and making it one of few companies operating in the mining space to pay a dividend.

It should be noted that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X